Increased circulating soluble urokinase-type plasminogen activator receptor (suPAR) levels in patients with slow coronary flow

التفاصيل البيبلوغرافية
العنوان: Increased circulating soluble urokinase-type plasminogen activator receptor (suPAR) levels in patients with slow coronary flow
المؤلفون: Izci Servet, Güler Ahmet, Efe Süleyman Çağan, Kırma Cevat, İzgi İbrahim Akın, Yılmaz Mehmet Fatih, Kılıçgedik Alev, Acar Emrah, Kahyaoğlu Muzaffer, Guler Yeliz
المصدر: Archives of Medical Sciences. Atherosclerotic Diseases
بيانات النشر: Termedia Sp. z.o.o., 2016.
سنة النشر: 2016
مصطلحات موضوعية: Urokinase, medicine.medical_specialty, business.industry, Inflammation, General Medicine, Gastroenterology, regression analysis, suPAR, Coronary arteries, medicine.anatomical_structure, SuPAR, Clinical Research, coronary slow flow, Internal medicine, medicine, high-sensitivity C-reactive protein, In patient, coronary angiography, medicine.symptom, Receptor, business, Pathological, Plasminogen activator, medicine.drug
الوصف: Introduction: Slow coronary flow (SCF) is an angiographic phenomenon characterized by delayed opacification of epicardial coronary arteries without an obstructive coronary disease. Serum soluble urokinase-type plasminogen activator receptor (suPAR) levels seem closely related to atherosclerosis due to increased inflammation and prothrombotic state. We studied whether circulating suPAR is related to SCF. Material and methods: The present study was cross-sectional and observational. It included 75 individuals who underwent coronary angiography with suspected CAD and had angiographically normal coronary arteries of varying coronary flow rates. The relationship between suPAR, C-reactive protein (CRP) and SCF was investigated. Forty patients with isolated SCF (mean age: 46.0 ±4.14 years) and 35 age- and gender-matched control participants with normal coronary flow (NCF) and normal coronary arteries (NCA) (mean age: 46.0 ±5.7 years) were included in the study. We used logistic regression analysis to determine the predictors of SCF. Results: The clinical characteristics were not statistically significantly different between SCF and NCA groups. Serum suPAR level was significantly higher in the SCF group than the control group (2.5–5.4 ng/ml vs. 0.1–1.4 ng/ml; p < 0.001). Also the serum CRP level was higher in the CSF group than the control group (1.57 ±0.43 mg/l vs. 0.53 ±0.23 mg/l; p < 0.001). Conclusions: This study revealed significantly increased serum suPAR levels in patients with SCF. Although we cannot draw conclusions on the underlying pathological process of SCF, we believe that these findings may be pioneering for further studies investigating the specific roles of circulating suPAR in the SCF phenomenon in the coronary vasculature.
تدمد: 2451-0629
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc1680edda6dd320f4b7d638aa862519Test
https://doi.org/10.5114/amsad.2016.60819Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....fc1680edda6dd320f4b7d638aa862519
قاعدة البيانات: OpenAIRE